Semaglutide is an FDA-approved medication that mimics GLP-1, a naturally occurring hormone in the body
Every medication offered through Mochi requires a prescription from the patient's provider after a live video consultation
Because the side effect profile of SGLT2is differs from that of GLP-1RAs, any additive negative interaction is not expected when these two classes of anti-diabetic medications are used in combination [11]
Tirzepatide as an alternative Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 agonist that some research suggests may preserve muscle better than semaglutide
In addition, the definitions of persistence and adherence are subject to potential inaccuracies
Most employers sit somewhere in the middle, where they would love to be delivering the right care that their employees are seeking with the option of GLP-1s, but want to see that done in a way that feels balanced with an overall budget and healthcare spend